Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAST Uveitis Trial
NCT01829295Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Aug 2013
- Primary completion
- Feb 2018
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of methotrexate, mycophenolate mofetil in uveitis, sponsored by University of California, San Francisco. Started Aug 2013; status: completed.
02
Drugs
methotrexatemycophenolate mofetil
03
Conditions
uveitis
Beyond the preview
Go deeper on NCT01829295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01829295.